OnabotulinumtoxinA

Details

Files

Generic Name:

OnabotulinumtoxinA

Project Status:

Complete

Therapeutic Area:

Migraine

Manufacturer:

Allergan Inc.

Call for patient/clinician input open:

July 12, 2013

Brand Name:

Botox

Project Line:

Reimbursement Review

Project Number:

SR0345-000

Call for patient/clinician input closed:

September 3, 2013

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Migraine, chronic

Recommendation Type:

Do not list

Final Recommendation:

May 28, 2014

Request for Resubmission: Eligible (Decision Date: June 5, 2018)

Last Updated : August 15, 2013